Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • sameet
    Member
    • Apr 2010
    • 34

    #1

    Comparing data across different chemistries/throughputs.

    Hi All,

    I have data from 6 RNA-Seq runs that we did sometime last year on a HiSeq machine. A month ago we tried the new MiSeq sequencer and I have one data-set from the new machine. How valid would be comparison between the two data-sets. Specifically, I have the following question.

    Would it be valid to compare these two data-sets. Especially considering that we get FPKM which would technically make comparison possible as the data-sets are independent of read-depth.

    Thanks in advance.
    Sameet Mehta (Ph.D.),
    Visiting Fellow,
    National Cancer Insitute,
    Bethesda,
    US.
  • westerman
    Rick Westerman
    • Jun 2008
    • 1104

    #2
    Hum. I haven't been on SeqAnswers for several days and am sort of surprised that no-one answered your question. I see no problems with comparing the two data sets assuming that the FPKMs are valid.

    Comment

    • JackieBadger
      Senior Member
      • Mar 2009
      • 385

      #3
      in one of our studies we compared data from the 454 FLX and 454 Junior machines. There is no reason why results should not be comparable. Plenty of studies compare and use data from different chemistries..... You should however do a thorough assessment of the error distributions between them. If they are not comparable, that is interesting in its own right.
      We are moving from 454 to MiSeq at the moment...one thing will be to compare the results between these data sets. These kind of questions need to be looked at with more rigour. Seeing as I am an Illumina greenhorn...are FPKM values some kind of quality score for contigs or sequences?
      If so, you are right that you really want to be comparing data of similar quality. We omitted a bunch of data which despite being at the same quality as a replicate data set, the mean depths were significantly different thus making accurate comparisons impossible. This all comes down to careful consideration of what goes into a run.
      j

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        How Immunogenomics Decodes Immunity’s Genetic Blueprint
        by SEQadmin2




        The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.

        This convergence of genetics, immunology, and computation...
        Today, 05:41 AM
      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 08-24-2026, 10:32 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-20-2026, 11:17 AM
      0 responses
      47 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-18-2026, 10:05 AM
      0 responses
      52 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-13-2026, 12:22 PM
      0 responses
      50 views
      0 reactions
      Last Post SEQadmin2  
      Working...